Stockscreener 앱 받기
1.234
2.06%
-0.026
시간 외 거래:
1.23
-0.004
-0.32%
전일 마감가:
$1.26
열려 있는:
$1.26
하루 거래량:
6,256
Relative Volume:
0.14
시가총액:
$5.21M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.0971
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
-0.48%
1개월 성능:
-29.89%
6개월 성능:
-37.36%
1년 성능:
-57.45%
1일 변동 폭
$1.234
$1.26
1주일 범위
$1.20
$1.36
52주 변동 폭
$0.952
$6.39
Tharimmune Inc Stock (THAR) Company Profile
명칭
Tharimmune Inc
전화
302-743-2995
주소
1200 ROUTE 22 EAST, BRIDGEWATER
THAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
1.234 | 5.61M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tharimmune Inc 주식(THAR)의 최신 뉴스
Tharimmune Inc. stock trend outlook and recovery pathPredictive Screener for Daily Trade Watch - Newser
Using fundamentals and technicals on Tharimmune Inc.Long Term Stock Planner with Safety Checks - Newser
Has Tharimmune Inc. Stock Ever Crashed Historical Volatility ReviewMonthly Trade Result and Signal Summary - Newser
Applying Wyckoff theory to Tharimmune Inc. stockDay Trading Setup and Momentum Analysis - Newser
Analyzing drawdowns of Tharimmune Inc. with statistical toolsAI Intraday Market Movement Prediction Tool - Newser
Chart based analysis of Tharimmune Inc. trendsBuy and Hold Return Summary with Charts - Newser
What risks could impact Tharimmune Inc. stock performanceStock Performance Summary Over One Year - Newser
What makes Tharimmune Inc. stock price move sharplyEquity Forecast with Predictive AI Screener - Newser
What machine learning models say about Tharimmune Inc.Trading Volume Spike and Reversal Analysis - Newser
Is Tharimmune Inc. showing insider buyingBest Value for High Returns - thegnnews.com
Tharimmune Appoints Nancy Davis to Board of Directors - TipRanks
Using AI based signals to follow Tharimmune Inc.High Win Rate Strategy with Stop Protection - Newser
What indicators show strength in Tharimmune Inc.AI Pattern Recognition and Trade Prediction - Newser
Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery - The Florida Times-Union
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors - Corsicana Daily Sun
Race to Erase MS Founder Who Raised $56M Joins Biotech Board to Fight Addiction Crisis - Stock Titan
Watch for Bullish Crossover in Tharimmune Inc.Alpha Driven Watchlist With Alerts Published - beatles.ru
Tharimmune Advances Fentanyl Defense Solution, Breakthrough Oral Antibody Technology | THAR Stock News - Stock Titan
Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants - Asbury Park Press
How does Tharimmune Inc. generate profit in a changing economyRemarkable growth - Jammu Links News
When is Tharimmune Inc. stock expected to show significant growthInvest smarter with real-time trading signals - Jammu Links News
Is it the right time to buy Tharimmune Inc. stockExceptional earning trajectories - Jammu Links News
What are analysts’ price targets for Tharimmune Inc. in the next 12 monthsInvest smarter with advanced market data - Jammu Links News
What drives Tharimmune Inc. stock priceBuild wealth faster with high-performing stocks - Jammu Links News
What is Tharimmune Inc. company’s growth strategyUnprecedented profits - Jammu Links News
Why is Tharimmune Inc. stock attracting strong analyst attentionUnlock your trading potential with expert tips - Jammu Links News
What catalysts could drive Tharimmune Inc. stock higher in 2025Capitalize on market momentum for maximum gains - Jammu Links News
What are Tharimmune Inc. company’s key revenue driversGet real-time alerts on top-performing stocks - Jammu Links News
AI Trend Models Suggest Bounce for Tharimmune Inc.Stock Portfolio Allocation Guidance for Volatile Markets - beatles.ru
Intrinsic Value of Tharimmune Inc. Stock: Is It Undervalued or OvervaluedVolume Confirmed Setup with Entry Confidence - Newser
How volatile is Tharimmune Inc. stock compared to the marketRetirement Planning Review With Proven Results - Jammu Links News
How strong is Tharimmune Inc. company’s balance sheetExpert Picks Tips With High Returns - Jammu Links News
Can a trend reversal in Tharimmune Inc. lead to recoverySecure Entry Point Finder with Analysis - Newser
Tharimmune Inc (THAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):